Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Royalty Pharma plc - Class A Ordinary Shares (NQ:RPRX)

36.33 +1.05 (+2.98%)
Streaming Delayed Price Updated: 2:38 PM EDT, Oct 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,651,330
Open 35.66
Bid (Size) 36.32 (3)
Ask (Size) 36.33 (3)
Prev. Close 35.28
Today's Range 35.53 - 36.35
52wk Range 24.05 - 38.00
Shares Outstanding 388,132,400
Dividend Yield 2.42%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Royalty Pharma Appoints Dr. Ted W. Love As Lead Independent Director
From Royalty Pharma plc
Via GlobeNewswire
Royalty Pharma to Present at Bernstein’s 2nd Annual Healthcare Forum
From Royalty Pharma plc
Via GlobeNewswire

Performance

YTD
+40.9%
+40.9%
1 Month
+0.4%
+0.4%
3 Month
+1.3%
+1.3%
6 Month
+16.6%
+16.6%
1 Year
+28.4%
+28.4%

More News

Read More
1 Safe-and-Steady Stock with Promising Prospects and 2 We Ignore
Via StockStory
How Do Investors Really Feel About Royalty Pharma?
Via Benzinga
Royalty Pharma Investor Day Highlights Strong Growth Outlook and Company’s Plans to Drive Value Creation
From Royalty Pharma plc
Via GlobeNewswire
Royalty Pharma Announces Release of Deloitte’s Report on the Biopharma Royalty Market
From Royalty Pharma plc
Via GlobeNewswire
1 Mid-Cap Stock with Exciting Potential and 2 Facing Challenges
Via StockStory
Topics Economy
Royalty Pharma to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
From Royalty Pharma plc
Via GlobeNewswire
Royalty Pharma Announces Pricing of $2.0 Billion of Senior Unsecured Notes
From Royalty Pharma plc
Via GlobeNewswire
Royalty Pharma and Zenas BioPharma Enter Into Obexelimab Funding Agreement for Up to $300 Million
From Royalty Pharma plc
Via GlobeNewswire
Zenas BioPharma and Royalty Pharma Enter into Obexelimab Funding Agreement for up to $300 Million
From Zenas BioPharma
Via GlobeNewswire
1 of Wall Street’s Favorite Stock to Keep an Eye On and 2 We Brush Off
Via StockStory
BeOne Cashes In On Amgen's Cancer Drug Royalties In Multibillion-Dollar Pharma Tie-Up
Via Benzinga
Royalty Pharma to Acquire Royalty Interest in Amgen’s Imdelltra for up to $950 Million
From Royalty Pharma plc
Via GlobeNewswire
1 Value Stock with Exciting Potential and 2 We Avoid
Via StockStory
Royalty Pharma PLC - Class A (NASDAQ:RPRX) Shows Strong Technical Breakout Potential with High ChartMill Ratings
Via Chartmill
1 Healthcare Stock for Long-Term Investors and 2 We Ignore
Via StockStory
Topics Stocks
Henry Fernandez Steps Down from Royalty Pharma's Board of Directors
From Royalty Pharma plc
Via GlobeNewswire
Here's How Much $1000 Invested In Royalty Pharma 15 Years Ago Would Be Worth Today
Via Benzinga
RPRX Q2 Deep Dive: Margins Compress Despite Solid Royalty Growth and Strategic Investments
Via StockStory
Reflecting On Branded Pharmaceuticals Stocks’ Q2 Earnings: Royalty Pharma (NASDAQ:RPRX)
Via StockStory
Topics Artificial Intelligence Intellectual Property
Royalty Pharma (RPRX) Q2 Receipts Up 20%
Via The Motley Fool
Royalty Pharma PLC (NASDAQ:RPRX) Exceeds Q2 2025 Earnings Estimates and Raises Full-Year Guidance
Via Chartmill
Royalty Pharma (NASDAQ:RPRX) Misses Q2 Revenue Estimates
Via StockStory
Royalty Pharma Reports Second Quarter 2025 Results
From Royalty Pharma plc
Via GlobeNewswire

Frequently Asked Questions

Is Royalty Pharma plc - Class A Ordinary Shares publicly traded?
Yes, Royalty Pharma plc - Class A Ordinary Shares is publicly traded.
What exchange does Royalty Pharma plc - Class A Ordinary Shares trade on?
Royalty Pharma plc - Class A Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Royalty Pharma plc - Class A Ordinary Shares?
The ticker symbol for Royalty Pharma plc - Class A Ordinary Shares is RPRX on the Nasdaq Stock Market
What is the current price of Royalty Pharma plc - Class A Ordinary Shares?
The current price of Royalty Pharma plc - Class A Ordinary Shares is 36.33
When was Royalty Pharma plc - Class A Ordinary Shares last traded?
The last trade of Royalty Pharma plc - Class A Ordinary Shares was at 10/01/25 02:38 PM ET
What is the market capitalization of Royalty Pharma plc - Class A Ordinary Shares?
The market capitalization of Royalty Pharma plc - Class A Ordinary Shares is 14.10B
How many shares of Royalty Pharma plc - Class A Ordinary Shares are outstanding?
Royalty Pharma plc - Class A Ordinary Shares has 14B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.